Key facts
- Lin Health’s last known valuation is $40.0M (Dec 2025).
- It has raised $26.1M; the latest was Later Stage VC ($11.0M) in Dec 2025.
- Notable investors include Viola Ventures, Mayo Clinic Ventures, NewHealth Ventures, Osage Venture Partners, Proofpoint — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Lin Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Lin Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lin Health
Developer of an online chronic pain recovery platform designed for the treatment and management of chronic pain conditions. The company's platform incorporates evidence-based nervous system signaling techniques, multidisciplinary clinical guidance, high-frequency coaching, and digital resources, enabling patients, providers, and payers to access compassionate, low-risk, and holistic care as an adjunct or alternative to opioids and allows patient with rapid onboarding, integration with major health plans, and improved outcomes, supporting both patient recovery and provider capacity.
- Sector
- Healthcare
- HQ
- Dover, DE, United States
- Founded
- 2020
- Employees
- 15
- Website
- lin.health/
- Ownership
- Privately Held (backing)
Lin Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lin Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lin Health in its N-PORT filings yet. We sweep new filings monthly.